Histology and molecular biology studies on the expression and localization of angiopoietin‑like protein 8 in human tissues

Akimoto,Naohiko; Wada,Ryuichi; Iwakiri,Katsuhiko; Naito,Zenya

doi:10.3892/br.2019.1243

Histology and molecular biology studies on the expression and localization of angiopoietin‑like protein 8 in human tissues

Authors:
- Naohiko Akimoto
- Ryuichi Wada
- Katsuhiko Iwakiri
- Zenya Naito
View Affiliations

Affiliations: Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113‑8602, Japan, Department of Gastroenterology, Nippon Medical School, Tokyo 113‑8602, Japan
Published online on: September 25, 2019 https://doi.org/10.3892/br.2019.1243
Pages: 215-221

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Angiopoietin‑like protein (ANGPTL) 8 regulates the partitioning of triglycerides by inhibiting lipoprotein lipase in muscle and adipose tissues. ANGPTL8 is expressed in the liver and adipose tissue and secreted into the blood. However, the precise localization of ANGPTL8‑expressing cells in these tissues remains unknown. The aim of the present study was to investigate the localization of ANGPTL8‑expressing cells in human tissues. Using formalin‑fixed paraffin‑embedded human tissue specimens, the expression of ANGPTL8 was investigated by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR), immunohistochemistry (IHC) and in situ hybridization (ISH). The expression level of ANGPTL8 mRNA was the highest in the liver, followed by lipoma, hibernoma and normal adipose tissue. In the liver, wild type (KF809856) and two splice variants of ANGPTL8 mRNA (KF809857 and KF809858) were found to be expressed. The expression level of the splice variant KF809858, which produces a short form of ANGPTL8, accounted for <1% of ANGPTL8 in the liver. IHC revealed that ANGPTL8 was expressed in hepatocytes in zone 1 of the hepatic acinus in the liver. In the adipose tissue, mature adipocytes weakly expressed ANGPTL8, while immature adipocytes strongly expressed it. ISH confirmed ANGPTL8 mRNA expression in portal hepatocytes and immature adipocytes. ANGPTL8 was expressed in the cells, which actively uptake and metabolize triglycerides. In hibernoma, the ANGPTL8 protein and mRNA were homogeneously expressed in tumor cells. The expression of ANGPTL8 was associated with the differentiation state and activity of lipid metabolism in a subpopulation of cells in the liver and adipose tissue. The association may be helpful for the understanding of local metabolic state in organs and diseases associated with the lipid metabolism.

View Figures

View References

1	Li Y and Teng C: Angiopoietin-like proteins 3, 4 and 8 regulating lipid metabolism and providing new hope for metabolic syndrome. J Drug Target. 22:679–687. 2014.PubMed/NCBI View Article : Google Scholar
2	Ren G, Kim JY and Smas CM: Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 303:E334–E351. 2012.PubMed/NCBI View Article : Google Scholar
3	Dong XY, Pang XW, Yu ST, Su YR, Wang HC, Yin YH, Wang YD and Chen WF: Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization method. Int J Cancer. 112:239–248. 2004.PubMed/NCBI View Article : Google Scholar
4	Fu Z, Yao F, Abou-Samra AB and Zhang R: Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun. 430:1126–1131. 2013.PubMed/NCBI View Article : Google Scholar
5	Yi P, Park JS and Melton DA: Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell. 153:747–758. 2013.PubMed/NCBI View Article : Google Scholar
6	Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E, Valenzuela DM, Murphy AJ, Cohen JC and Hobbs HH: Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci USA. 109:19751–19756. 2012.PubMed/NCBI View Article : Google Scholar
7	Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela DM, Cohen JC and Hobbs HH: Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA. 110:16109–16114. 2013.PubMed/NCBI View Article : Google Scholar
8	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
9	Hijmans BS, Grefhorst A, Oosterveer MH and Groen AK: Zonation of glucose and fatty acid metabolism in the liver Mechanism and metabolic consequences. Biochimie. 96:121–129. 2014.PubMed/NCBI View Article : Google Scholar
10	von Loeffelholz, Pfeiffer AFH, Lock JF, Lieske S, Docke S, Murahovschi V, Kriebel J, de Las Heras Gala, Grallert H, Rudovich N, et al: ANGPTL8 (Betatrophin) is expressed in visceral adipose tissue and relates to human hepatic steatosis in two independent clinical collectives. Horm Metab Res. 49:343–349. 2017.PubMed/NCBI View Article : Google Scholar
11	Lee YH, Lee SG, Lee CJ, Kim SH, Song YM, Yoon MR, Jeon BH, Lee JH, Lee BW, Kang ES, et al: Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease Animal and human studies. Sci Rep. 6(24013)2016.PubMed/NCBI View Article : Google Scholar
12	Mysore R, Liebisch G, Zhou Y, Olkkonen VM and Nidhina Haridas PA: Angiopoietin-like 8 (Angptl8) controls adipocyte lipolysis and phospholipid composition. Chem Phys Lipids. 207:246–252. 2017.PubMed/NCBI View Article : Google Scholar
13	Vatner DF, Goedeke L, Camporez JG, Lyu K, Nasiri AR, Zhang D, Bhanot S, Murray SF, Still CD, Gerhard GS, et al: Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia. 61:1435–1446. 2018.PubMed/NCBI View Article : Google Scholar
14	Yu YH and Zhu H: Chronological changes in metabolism and functions of cultured adipocytes A hypothesis for cell aging in mature adipocytes. Am J Physiol Endocrinol Metab. 286:E402–E410. 2004.PubMed/NCBI View Article : Google Scholar
15	Siddiqa A, Ahmad J, Ali A, Paracha RZ, Bibi Z and Aslam B: Structural characterization of ANGPTL8 (betatrophin) with its interacting partner lipoprotein lipase. Comput Biol Chem. 61:210–220. 2016.PubMed/NCBI View Article : Google Scholar
16	Tseng YH, Yeh YH, Chen WJ and Lin KH: Emerging regulation and function of betatrophin. Int J Mol Sci. 15:23640–23657. 2014.PubMed/NCBI View Article : Google Scholar
17	Haller JF, Mintah IJ, Shihanian LM, Stevis P, Buckler D, Alexa-Braun CA, Kleiner S, Banfi S, Cohen JC, Hobbs HH, et al: ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance. J Lipid Res. 58:1166–1173. 2017.PubMed/NCBI View Article : Google Scholar
18	Nidhina Haridas PA, Soronen J, Sadevirta S, Mysore R, Quagliarini F, Pasternack A, Metso J, Perttila J, Leivonen M, Smas CM, et al: Regulation of angiopoietin-like proteins (ANGPTLs) 3 and 8 by insulin. J Clin Endocrinol Metab. 100:E1299–E1307. 2015.PubMed/NCBI View Article : Google Scholar
19	Kovrov O, Kristensen KK, Larsson E, Ploug M and Olivecrona G: On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity. J Lipid Res. 60:783–793. 2019.PubMed/NCBI View Article : Google Scholar
20	Guo T, Yin RX, Wu J, Lin QZ, Shi GY, Shen SW, Sun JQ, Li H, Lin WX and Yan DZ: Association of the angiopoietin-like protein 8 rs2278426 polymorphism and several environmental factors with serum lipid levels. Mol Med Rep. 12:3285–3296. 2015.PubMed/NCBI View Article : Google Scholar
21	Liu J, Yagi K, Nohara A, Chujo D, Ohbatake A, Fujimoto A, Miyamoto Y, Kobayashi J and Yamagishi M: High frequency of type 2 diabetes and impaired glucose tolerance in Japanese subjects with the angiopoietin-like protein 8 R59W variant. J Clin Lipidol. 12:331–337. 2018.PubMed/NCBI View Article : Google Scholar
22	Espes D, Lau J and Carlsson PO: Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia. 57:50–53. 2014.PubMed/NCBI View Article : Google Scholar
23	Hu H, Sun W, Yu S, Hong X, Qian W, Tang B, Wang D, Yang L, Wang J, Mao C, et al: Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care. 37:2718–2722. 2014.PubMed/NCBI View Article : Google Scholar
24	Ebert T, Kralisch S, Wurst U, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Tönjes A and Fasshauer M: Betatrophin levels are increased in women with gestational diabetes mellitus compared to healthy pregnant controls. Eur J Endocrinol. 173:1–7. 2015.PubMed/NCBI View Article : Google Scholar
25	Gusarova V, Alexa CA, Na E, Stevis PE, Xin Y, Bonner-Weir S, Cohen JC, Hobbs HH, Murphy AJ, Yancopoulos GD and Gromada J: ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell. 159:691–696. 2014.PubMed/NCBI View Article : Google Scholar
26	Yi P, Park JS and Melton DA: Retraction notice to Betatrophin A hormone that controls pancreatic β cell proliferation. Cell. 168(326)2017.PubMed/NCBI View Article : Google Scholar
27	Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TM and Kiefer FW: Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 57:1204–1208. 2014.PubMed/NCBI View Article : Google Scholar